On 25–26 November 2019, the Indian Council of Medical Research (ICMR) and the Global Antibiotic Research and Development Partnership (GARDP) organized a two-day workshop to map out the opportunities, challenges and practicalities of carrying out clinical trials of new antibiotics in India. Held at the ICMR headquarters in New Delhi, India, the workshop brought together […]
The Global Antibiotic Research & Development Partnership (GARDP) is delighted to announce a collaboration with international yoga star Tara Stiles to raise funds to fight drug-resistant infections in the midst of the coronavirus disease (COVID-19) pandemic. Ms Stiles, who is the founder of Strala Yoga, has launched a new collection of T-shirts entitled “The Feel […]
The COVID-19 pandemic was anticipated and could have been avoided. Faced with antibiotic resistance, pharmaceuticals and governments could be doing much more, warns Manica Balasegaram, Executive Director of GARDP.
On STD Awareness Week (12-18 April), we’re celebrating advances made against gonorrhoea, while casting a light on a harsh truth. Despite being preventable and treatable, gonorrhoea is on the rise. More partnerships are needed, and must move faster, to support research, development and access to new treatments for gonorrhoea and other curable STIs, for every person who needs them.
The Global Antibiotic Research and Development Partnership (GARDP) announced today that with their partners St George’s University of London and the Paediatric Infectious Disease Network (Penta), they have completed recruitment for their neonatal sepsis observational study. The observational study has recruited more than 3,200 newborns across 19 sites in 11 countries. Reaching this important milestone […]